MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison
NCT04652947 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2020-12-03
Summary
Compare diagnostic MRI performance of gadoteric acid, gadoxetic acid and P03277 for suspected CHC nodules less than 3 cm, using LIRADS criteria
Conditions
Interventions
- DIAGNOSTIC_TEST
-
MRI diagnostic
no intervention, patient only have MRI
Sponsors & Collaborators
-
University Hospital, Angers
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-07
- Primary Completion
- 2017-10-26
- Completion
- 2017-10-26
More Related Trials
-
Evaluation of 4 MRI Methods (PDFF 3, 6 and 11 Gradient Echoes and Spectroscopy) Compared to the Reference Method (Liver Biopsy) in Quantification of Hepatic Steatosis
NCT03142698 ·Status: UNKNOWN ·Phase: NA
-
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
NCT06537193 ·Status: RECRUITING ·Phase: NA
-
Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules
NCT04687280 ·Status: COMPLETED
-
Establishment of Scoring Model for Early and Differential Diagnosis of Intrahepatic Cholangiocarcinoma
NCT05327907 ·Status: UNKNOWN
-
Role of Abbreviated MRI in Follow-up of Hepatocellular Carcinoma .
NCT06168357 ·Status: NOT_YET_RECRUITING
-
Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk
NCT06312826 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phenotyping Liver Cancer Registry
NCT04681274 ·Status: COMPLETED
-
Abbreviated MRI for HCC Surveillance
NCT03731923 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis
NCT01575574 ·Status: COMPLETED ·Phase: PHASE4
-
Ga-68 Dolacga PET Scan in HCC Under RFA
NCT06792097 ·Status: NOT_YET_RECRUITING
-
Comparison of Gd-EOB-DTPA-enhanced MRI and Contrast-enhanced Ultrasound for Measuring Tumor Size of Solitary Hepatocellular Carcinoma ≤ 5cm:A Retrospective Study
NCT06437457 ·Status: COMPLETED
-
Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular Carcinoma
NCT03892681 ·Status: UNKNOWN ·Phase: NA
-
CT Image-assisted Detection Software for Focal Liver Lesions
NCT06068413 ·Status: COMPLETED ·Phase: NA
-
Quantification of Hepatic Fibrosis by IVIM Sequences in 1.5T MRI
NCT03173287 ·Status: UNKNOWN ·Phase: NA
-
FAST (Focused Abbreviated Screening Technique)-MRI Study
NCT04539717 ·Status: ENROLLING_BY_INVITATION
-
Diagnostic Accuracy of Magnetic Resonance Cholangiopancreatography in Patients With Obstructive Jaundice
NCT06754397 ·Status: NOT_YET_RECRUITING
-
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC
NCT04212286 ·Status: COMPLETED ·Phase: NA
-
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
NCT01390194 ·Status: COMPLETED
-
Repeatability and Reproducibility of Multiparametric MRI
NCT03743272 ·Status: COMPLETED
-
Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents
NCT01341132 ·Status: UNKNOWN
-
Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI
NCT02854371 ·Status: COMPLETED ·Phase: PHASE4
-
Fully Automated High-Throughput Quantitative MRI of the Liver
NCT05294471 ·Status: RECRUITING
-
Correlation Between CEUS Identification of Nodular HPD on CE-MRI and Hepatic Malignant Lesions
NCT06816212 ·Status: ENROLLING_BY_INVITATION
-
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)
NCT01116804 ·Status: COMPLETED ·Phase: PHASE1
-
New Diagnostic Criteria in the Evaluation Response to Ablation Treatment of Hepatocellular Carcinoma Nodules
NCT07272083 ·Status: NOT_YET_RECRUITING